在解剖肺切除后的术后心房动:一个病例报告和现代药理学管理的叙述审查
Jordan Sauve1, Colin R Tang-Whitmore1, Zoe Randall1
1Department of Surgery, University of Minnesota, Minneapolis, USA.
Cureus
|September 8, 2025
概括
肺切除后的术后心房动 (POAF) 是常见的. 阿米奥达龙显示有效性和耐受性,但个性化风险评估对于胸部手术患者的最佳管理至关重要.
科学领域:
- 心脏病学 心脏病学
- 胸部外科手术 胸部外科手术
- 药理学 药理学是指药理学的学科.
背景情况:
- 手术后心房动 (POAF) 是解剖肺切除后的常见并发症.
- POAF增加了发病率,死亡率,住院时间和医疗费用.
- 在这个人群中对POAF的最佳药理管理存在有限的共识.
研究的目的:
- 突出POAF在胸部手术中的临床意义,特别是在肺切除后.
- 介绍VATS叶切除术后的POAF病例,并审查当前的文献和指导方针.
- 讨论肺切除患者POAF的药理管理策略.
主要方法:
- 进行了PubMed和Scopus的文献综述,以药理管理POAF肺部抽除术后的药理管理.
- 纳入标准侧重于额叶切除术后新发性POAF的成年患者,不包括先前存在的AF或非额叶切除术手术.
- 在VATS细分切除术后呈现并分析了一例POAF与RVR的病例.
主要成果:
- 证据支持阿米奥达龙,β阻断剂,通道阻断剂和用于POAF预防和治疗.
- 阿米奥达龙在所介绍的病例和文献中显示出有效性和良好的耐受性.
- 审查强调了需要针对肺部特定的,基于证据的POAF管理指南.
结论:
- 在解剖肺切除后管理POAF是复杂的,需要量身定制的方法.
- 在这种情况下,阿米奥达龙等药理学药物是有效和安全的.
- 个性化风险评估对于优化胸部手术患者的POAF治疗至关重要.
相关概念视频
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
290
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
290
01:25Aortic Regurgitation III: Medical Management
401
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
401
01:22Aneurysm IV: Nursing Management
392
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
392
01:27Pulmonary Embolism III: Nursing Management
369
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
369
01:23Peripheral Artery Disease V: Postoperative Nursing Management
379
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
379
01:27Pneumothorax-II
928
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
928